Related by context. Frequent words. (Click for all words.) 67 Completes Patient Enrollment 67 YOUR LOCAL ANIMAL SHELTER 66 Receives Orphan Drug Designation 65 Presents Positive 65 * Azixa 65 PINNACLEDIGEST.COM S PAST PERFORMANCE 65 By Thomas Gryta 65 Initiates Phase II 65 Inc Therapeutic Competitors 65 R bortezomib 65 development diagnostics combinatorial 65 Completes Enrollment 65 Marcus Gronholm BP 65 ® bortezomib 65 HOW LONG WAS 65 By SABINA DANA 64 Potassium Chloride Sodium Ascorbate 64 www.syntapharma.com 64 www.BMRN.com 64 www.vivus.com 64 By TERRANCE HARRIS 64 CORT # 64 Meets Primary Endpoint 64 CD#.# DOES NOT ENDORSE 63 inflammatory autoimmune diseases 63 Recombinant Human 63 BY JASON THOMPSON 63 Joseph Levi Esq 63 2 methoxyestradiol 63 Calls Purchased 63 topical non steroidal 63 Inc. Nasdaq IMGN 63 orderonlineviagra 63 please visit http:/www.supergen.com 63 IS NOT INDICATIVE OF 63 AMB invests 63 Attracting Bullish Investors 63 non personalized allogeneic 63 www.polymedix.com 63 Therapeutic Competitors 63 Cloud Headed Next 62 ACTUAL RESULTS COULD DIFFER 62 Takeda Kyowa Hakko Kirin 62 TRISCUIT crackers 62 Drug Candidate 62 phenylketonuria PKU developed 62 RELATIVELY GOOD PERFORMANCE DETECTED 62 specific ZFP Nucleases 62 HYPOTHETICAL OR SIMULATED PERFORMANCE 62 VEGFR2 inhibitor 62 phenylalanine ammonia lyase 62 CONTAINS FORWARD LOOKING STATEMENTS 62 AUCTIONEERS UNAUTHORIZED USE 62 Cet article ne reflète 62 Advancing Drugs 62 DRRX 62 OR SIMILAR STATEMENTS ARE 62 www.biodel.com 62 SEE CONTINUED UPWARD MOMENTUM 62 Inc. NASDAQ MBLX 62 Entereg R 62 By BILL PLUNKETT 62 Panzem R 62 R sorafenib tablets 62 PET FROM 62 BELIEVES THAT THE 62 Inc. NASDAQ QLTI 62 SHALL NOT CONSTITUTE AN 62 By Priyanka Dayal 62 IS FOR INFORMATIONAL 62 http:/www.nabi.com 62 Nasdaq ENMD 62 By FRAN SYPEK 62 refractory chronic lymphocytic 62 fibrosis IPF 62 Vytorin combines 62 belmond@theacorn.com 61 YET BEEN CERTIFIED 61 www.transcept.com 61 RHF Seven Summits Strategic 61 AS ESTIMATE ANTICIPATE BELIEVE 61 MAY CONTAIN FORWARD LOOKING 61 REPORTS FILED FROM 61 MATTERS DISCUSSED IN 61 HAS BEEN PREPARED BY 61 addressing idiopathic pulmonary 61 METHODOLOGIES ARE AVAILABLE FROM 61 ARE MADE AS 61 Anti Tumor 61 By DAN MURTAUGH 61 ZFN TM 61 Regulatory Disclosure 61 MGCD# MGCD# [001] 61 By PETER LARSEN 61 LAW IS NOT 61 PLAN OR EXPECT 61 MKC# 61 III dtfoster@charlotteobserver.com 61 OR WEB SITE 61 www.spectrumpharm.com 61 Western Service http:/www.shns.com